On September 28, 2016, the 15th participant was enrolled at our study site in Charleston, South Carolina in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. The Charleston site is led by Principal Investigator Michael Mithoefer, M.D. On October 23, the third participant was enrolled at the recently initiated Boulder, Colorado study site. Marcela Ot’alora, M.A., L.P.C., is serving as Principal Investigator of the Boulder site. Enrollment in this study is limited by invitation only to therapists in training to work on MAPS-sponsored clinical trials of MDMA-assisted psychotherapy for PTSD. This study has currently enrolled 18 out of 100 participants across both study sites. Learn more…
